COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,312 Articles (22,772 medRxiv, 8,540 bioRxiv)

Most recent first Previous |  Page 40: Articles 391-400  | Next

Potent broad-spectrum anti-coronaviral frameshift inhibitors from virtual screen of RNA binding
Neupane, K., Sekar, R. V., Ileperuma, S. M., Reklow, E., Munshi, S., Omar, S. I., Arbabimoghadam, S., Peterson, J. A., Tuszynski, J. A., Hobman, T. C., Woodside, M. T.
10.1101/2025.09.17.676934 — Posted: 2025-09-18
Effects of Working from Home on Musculoskeletal Pain and Coronaphobia during the COVID-19 Pandemic
Castelo, L. A., Junior, N. C., Civile, V. T., Costa, J. M., Matos, R. R., Trevisani, V. F.
10.1101/2025.09.16.25335923 — Posted: 2025-09-17
Mechanisms for cross-neutralisation of diverse bat sarbecoviruses
Upadhyay, A., Seow, J., Alguel, Y., Newman, J., Thakur, N., Hay, A., Tam, J. C. H., Nans, A., Orton, R., Bailey, D., Cherepanov, P., Doores, K. J.
10.1101/2025.09.17.674891 — Posted: 2025-09-17
mRNA-1273.251 and mRNA-1283.251 vaccines expressing SARS-CoV-2 variant LP.8.1 antigens broadly neutralize contemporary JN.1-lineage viruses
Nasir, A., Lee, D. W., Wang, Z., Ogega, C., Bopp, N., Wisti, P., Makrinos, D., Jani, H., Gorrie, A., Bender, M. F., Laciak, A. R., Sharma, A., Hu, X., Speidel, T., Ghantous, F., Berrueta, D. M., Hou, Y. J., Hardcastle, K., Elbashir, S., Harmon, C., Amato, N. J., Wu, K., Schief, W. R., Hohn, K., Carfi, A., Budigi, Y., Wahid, R., Edwards, D. K., Freyn, A. W.
10.1101/2025.09.16.676634 — Posted: 2025-09-17
HUBMet: An integrative database and analytical platform for human blood metabolites and metabolite-protein associations
Wang, X., Qiao, X., Zenere, A., Barde, S., Wang, J., Zhong, W.
10.1101/2025.09.16.676477 — Posted: 2025-09-17
Sarbecovirus Rc-o319 S-Protein Structures Reveal Highly Specialized Adaptation to Rhinolophus cornutus ACE2
Wang, J., Li, Z., Ma, Y., Li, Z., Yuan, H., Niu, C., Liu, B., Li, M., Zhou, M., Liu, W., Feng, H., Chen, J., He, J., Chen, X., Xiong, X.
10.1101/2025.09.17.676762 — Posted: 2025-09-17
Economic crisis and post-COVID adaptations in Directly Observed Therapy practices among tuberculosis patients in Colombo, Sri Lanka: A cross-sectional study
Alahakoon, T., Jayaweera, R., Asienga, D., Wagaman, A. S., Purdy, A. E., Rajapakshe, O. B. W.
10.1101/2025.09.15.25335789 — Posted: 2025-09-16
Metabolic Signatures of Pulmonary Embolism in COVID-19: Insights from Longitudinal Intensive Care Unit Profiles
Valdez, M. E., Janssen, M., Zhang, Z., Lamont, L., Singh, M., Yang, W., Nijgh - van Kooij, C., Geerlings, J., Ali, A., Karu, N., de Rijke, Y. B., Harms, A. C., Kindt, A., Gommers, D., Endeman, H., Hankemeier, T.
10.1101/2025.09.12.675971 — Posted: 2025-09-16
Evaluation of Antigen Expression and Early Immune Response following Cutaneous Suction-mediated DNA Delivery
Jhumur, N. C., Um, Y., Park, S. H., Lallow, E. O., Roberts, C. C., Shan, J. W., Singer, J. P., Zahn, J. D., Park, Y. K., Denzin, L. K., Shreiber, D. I., Maslow, J. N., Lin, H.
10.1101/2025.09.15.676388 — Posted: 2025-09-16
An allele-based evolution model of the population spread of SARS-CoV-2
Koopman, J. S., Eisenberg, M. C., Polanco, A., Simon, C. P.
10.1101/2025.09.15.25335781 — Posted: 2025-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).